NCT02489162

Brief Summary

The objective of the research is to determine whether the MyotonPRO has a valid and reliable application in facial, head and neck surgery. In addition, the study aims to compare this new technology with current electromyography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2015

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

November 18, 2025

Status Verified

October 1, 2018

Enrollment Period

3.3 years

First QC Date

June 10, 2015

Last Update Submit

November 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Muscle tone (Hz)

    Determine the feasibility of the MyotonPRO for assessing biomechanical properties of mimic muscles.

    12 months

Secondary Outcomes (1)

  • stiffness (N/m)

    12 months

Other Outcomes (1)

  • elasticity (Logarithmic decrement)

    12 months

Study Arms (2)

MyotonPRO

EXPERIMENTAL

Experimental: Measurement of biomechanical properties of mimic muscles on the ipsilateral palsy side with the healthy contralateral side ( case - control design)

Device: MyotonPRODevice: non-invasive electromyography (EMG)

Non-invasive electromyography (EMG)

ACTIVE COMPARATOR

Comparing experimental intervention with gold standard

Device: MyotonPRODevice: non-invasive electromyography (EMG)

Interventions

MyotonPRODEVICE

MyotonPRO measurements of the biomechanical properties of facial mimic muscles

MyotonPRONon-invasive electromyography (EMG)

Gold standard technique for measuring muscle

MyotonPRONon-invasive electromyography (EMG)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral peripheral facial nerve palsy
  • Mental capacity to give consent
  • The patient is able to sit independently

You may not qualify if:

  • Adults who have undertaken strenuous exercise within the last twenty-four hours
  • Adults taking prescription medication with a known effect on the mechanical properties of muscle (e.g. benzodiazepines) or receiving antispasmodic medications (e.g. botulinum A toxin)
  • Adults with poor mobility (unable to lie prone).
  • Adults with a body mass index (BMI) \>30 kg/m2 . Muscle measurements may be inaccurate with excessive subcutaneous tissue

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair Ziekenhuis Brussel

Jette, Brussels Capital, 1090, Belgium

Location

MeSH Terms

Conditions

Bell Palsy

Condition Hierarchy (Ancestors)

Herpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsMouth DiseasesStomatognathic DiseasesFacial Nerve DiseasesCranial Nerve DiseasesNervous System Diseases

Study Officials

  • John Blythe, FRCS

    European Face Centre, Universitair Ziekenhuis Brussel and University of Southhampton

    PRINCIPAL INVESTIGATOR
  • Maurice Mommaerts, Prof.Dr.Mult

    European Face Centre, Universitair Ziekenhuis Brussel

    STUDY CHAIR
  • Daniel Labbé, MD

    Saint Martin Private Hospital Caen

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2015

First Posted

July 2, 2015

Study Start

September 1, 2015

Primary Completion

December 1, 2018

Study Completion

April 1, 2019

Last Updated

November 18, 2025

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations